Catalyst Pharmaceuticals Reports Record Third Quarter 2022 Financial Results and Provides a Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. SPY
3. ABBV
4. IBM
5. META
6. MU
7. ACN
8. NVDA
9. FDX
10. BLZE

Go back to Catalyst Pharmaceuticals Reports Record Third Quarter 2022 Financial Results and Provides a Corporate Update

Catalyst Pharmaceuticals (CPRX) Tops Q3 EPS by 8c; Offers FY22 Revenue Guidance

November 9, 2022 4:37 PM EST

Catalyst Pharmaceuticals (NASDAQ: CPRX) reported Q3 EPS of $0.26, $0.08 better than the analyst estimate of $0.18. Revenue for the quarter came in at $57.2 million versus the consensus estimate of $53.62 million.

GUIDANCE:

Catalyst Pharmaceuticals sees FY2022 revenue of $205-210 million, versus the consensus of... More